QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32706672.
- Also identified by DOI 10.2196/19781 and PMC identifier 7414407.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.
Medical subject headings
- Blood Pressure Determination
- Diabetes Mellitus, Type 2